SARS, Spike Protein, Middle, Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

Catalog No : USB-S0098-17G
1331.07€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name SARS, Spike Protein, Middle, Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)
Catalog No USB-S0098-17G
Supplier’s Catalog No S0098-17G
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight 38
Storage -20°C
Other names
Grade Purified
Purity ~95% pure (10% PAGE Coomassie staining). GS-4B Sepharose Affinity Purification.
Form Supplied as a liquid in 25mM Tris-HCl, 0.4% sarcosyl, 0.25% Triton-X100, 50% glycerol.
Reactivity life 6 months
Note For reserch purpose only
Purity ~95% pure (10% PAGE Coomassie staining). GS-4B Sepharose Affinity Purification.
Description Contains a mosaic of the immunodominant regions of themiddle region of the Spike protein. Not full-length spike protein. Contains GST fusion partner. Immunoreactive with SARS positive sera. A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139kD protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells. Source: E. coli Molecular Weight: ~38kD. May appear as multiple bands on SDS-PAGE (intact protein at 35kD, GST fusion protein at 26kD, and the Spike fragment at 12kD). Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.